Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX)

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / Common Stock, par value $0.0001
Shares outstanding
53,041,500
Total 13F shares
10,049,202
Share change
+365,402
Total reported value
$217,102,831
Price per share
$21.76
Number of holders
51
Value change
+$13,927,748
Number of buys
37
Number of sells
19

Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q2 2018

As of 30 Jun 2018, Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) was held by 51 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,049,202 shares. The largest 10 holders included Polaris Venture Management Co. V, L.L.C., FMR LLC, DISCOVERY CAPITAL MANAGEMENT, LLC / CT, JENNISON ASSOCIATES LLC, Voya Investment Management LLC, BlackRock Inc., VANGUARD GROUP INC, BANK OF AMERICA CORP /DE/, FRONTIER CAPITAL MANAGEMENT CO LLC, and WELLINGTON MANAGEMENT GROUP LLP. This page lists 52 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.